The purpose of this study is to determine whether a specialized, technology-based training program in tobacco prevention is more effective than standard training for pediatric residents who counsel youth and their parents.

Condition	Treatment or Intervention	Phase
Tobacco Use Disorder	Behavior: Pediatric residency training on tobacco	Phase II

Further Study Details: 

Expected Total Enrollment:  4000

The American Academy of Pediatrics and other leading health agencies call upon pediatricians to address environmental tobacco smoke (ETS), prevent smoking onset in youths, and encourage cessation of tobacco use by adolescents and their parents. Systematic intervention on tobacco by pediatricians would protect infants and young children from the harmful effects of ETS and save adolescents from a lifetime of addiction and tobacco-related disease. Despite this, few pediatricians address tobacco use, and pediatric residency training programs are not preparing residents to play a leadership role in the anti-tobacco arena.

The Pediatric Residency Training on Tobacco project is a four-year randomized controlled study of the efficacy of a specialized tobacco intervention program for pediatric residents. Eight participating pediatric training sites were randomly assigned to a Special Training condition featuring "Solutions for Smoking", a hybrid CD-ROM/Website training program. Six sites were randomly assigned to a control condition that provided standard print literature. Key features of "Solutions for Smoking" include a website containing background material on tobacco, interviewing, behavioral and pharmacological aspects of intervention, and a series of CD-ROMs containing audio-visual vignettes that model state-of-the-art interviewing and tobacco intervention skills. Residents are expected to practice the interventions with patients in their Continuity Clinics, and all sites are provided with brochures and other intervention materials for this purpose. Study investigators meet with residents at all sites three times per year to discuss the program and the residents’ efforts to intervene on tobacco with their patients. Annually, second and third-year residents participate in Objective Structured Clinical Examinations (OSCEs) and a Resident Tobacco Survey. Patients and parents attending each of the Continuity Clinics complete Patient and Parent Tobacco Surveys at baseline and end of study.

Primary endpoints include changes over time in pediatric residents’ tobacco intervention knowledge, skills, and activities as reported on the Tobacco Surveys and measured by performance on the OSCEs at baseline and follow-up. Secondary endpoints include changes in smoking, other tobacco use, and control of ETS by patients and parents. The study hypothesizes that pediatric residents in both arms of the study will be similar in knowledge and skills at baseline; that residents in the specialized training program will acquire more knowledge and greater skills for tobacco intervention during the course of the study compared to residents in the control condition; and residents in each condition will increase the frequency in which they address tobacco in patients and parents.

Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

The training program will include all residents enrolled in the 14 participating residency training prgrams.

The Baseline and Follow-up Resident Tobacco Surveys and OSCEs will include all second and third year residents enrolled in the residency training programs at baseline and years 1, 2, and 3 of follow-up.

The Baseline and Follow-up Patient Tobacco Survey will include 30 patients, ages 12-21, who were present in the waiting areas of the Continuity Clinic when the surveys were administered. All patients present in the clinic will be approached and invited to participate. Partcipants must be able to read English or Spanish, and patients who are attending the clinic for the very first time will not be eligible to participate in the survey.

The Baseline and Follow-up Parent Tobacco Surveys will be administered to 100 parents (one per family) who are present in the clinic when the surveys are administered. Parents who cannot read English or Spanish and who are bringing their child to the clinic for the very first time will not be able to participate.

New Jersey
      UMDNJ-Robert Wood Johnson Medical School, Camden,  New Jersey,  08103-1489,  United States; Recruiting
      Mount Sinai School of Medicine (Jersey City Program), Jersey City,  New Jersey,  07304,  United States; Recruiting
      Jersey Shore Medical Center, Neptune,  New Jersey,  07754,  United States; Recruiting
      Newark Beth Israel Medical Center, Newark,  New Jersey,  07112,  United States; Recruiting
      St. Joseph's Hospital and Medical Center, Paterson,  New Jersey,  07503,  United States; Recruiting
New York
      Bronx/Lebanon Hospital, Bronx,  New York,  10457,  United States; Recruiting
      Lincoln Medical Center, Bronx,  New York,  10451,  United States; Recruiting
      Long Island College Hospital, Brooklyn,  New York,  11201,  United States; Recruiting
      Brooklyn Hospital Center Program, Brooklyn,  New York,  11212,  United States; Recruiting
      New York and Presbyterian Hospital (Cornell Campus) Program, New York City,  New York,  10021,  United States; Recruiting
      Woodhull Medical and Mental Health Center, Brooklyn,  New York,  11206-5317,  United States; Recruiting
      New York Flushing Hospital Medical Center, Flushing,  New York,  11355,  United States; Recruiting
      Nassau County Medical Center, East Meadow,  New York,  11554,  United States; Recruiting
      Winthrop-University Hospital Program, Mineola,  New York,  516-663-2288,  United States; Recruiting

Study chairs or principal investigators

Joseph Schwab, M.D.,  Principal Investigator,  New Jersey Medical School   

Study ID Numbers:  1R01HD40683-1
Record last reviewed:  December 2004
Last Updated:  December 3, 2004
Record first received:  December 3, 2004
ClinicalTrials.gov Identifier:  NCT00098215
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08